Cargando…

Identification of key genes and specific pathways potentially involved in androgen-independent, mitoxantrone-resistant prostate cancer

BACKGROUND: Resistance to mitoxantrone (MTX), an anthracenedione antineoplastic agent used in advanced and metastatic androgen-refractory prostate cancer (PCa), seriously limits therapeutic success. METHODS: Xenografts from two human PCa cell lines (VCaP and CWR22) were established in male severe co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Sha, Jiang, Lili, Wang, Liuyan, Wang, Lingli, Zhang, Cong, Ma, Yu, Huang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322516/ https://www.ncbi.nlm.nih.gov/pubmed/30655694 http://dx.doi.org/10.2147/CMAR.S179467

Ejemplares similares

Transcriptome analysis of differentially expressed genes and pathways associated with mitoxantrone treatment prostate cancer
por: Li, Sanqiang, et al.
Publicado: (2018)

Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
por: Crona, Daniel J., et al.
Publicado: (2017)

Mechanisms of Androgen-Independent Prostate Cancer
por: Saraon, Punit, et al.
Publicado: (2014)

Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer
por: Xu, Lingfan, et al.
Publicado: (2019)

Independence of HIF1a and androgen signaling pathways in prostate cancer
por: Tran, Maxine G. B., et al.
Publicado: (2020)

A novel approach to identify driver genes involved in androgen-independent prostate cancer
por: Schinke, Ellyn N, et al.
Publicado: (2014)

Estrogen Receptor Signaling Pathways Involved in Invasion and Colony Formation of Androgen-Independent Prostate Cancer Cells PC-3
por: Lombardi, Ana Paola G., et al.
Publicado: (2021)

FOXO3a-ROS pathway is involved in androgen-induced proliferation of prostate cancer cell
por: Tao, Yan, et al.
Publicado: (2022)

Arsenic and Prostate Cancer: Acquiring Androgen Independence
por: Tibbetts, John
Publicado: (2005)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer
por: Wang, Wenxuan, et al.
Publicado: (2022)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

Identification of an antibody fragment specific for androgen-dependent prostate cancer cells
por: Williams, Ryan M, et al.
Publicado: (2014)

Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells
por: Zhang, Ying, et al.
Publicado: (2021)

Intermittent chemotherapy in metastatic androgen-independent prostate cancer
por: Beer, T M, et al.
Publicado: (2003)

Regulation of expression of Na(+),K(+)-ATPase in androgen-dependent and androgen-independent prostate cancer
por: Blok, L J, et al.
Publicado: (1999)

Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer
por: Abd. Wahab, Nurul Azwa, et al.
Publicado: (2020)

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy
por: Wang, Yanqing, et al.
Publicado: (2016)

Towards understanding androgen receptor-independent prostate cancer: an evolving paradigm
por: Zhou, Jianfu, et al.
Publicado: (2020)

Identification of the key genes and pathways in prostate cancer
por: Fan, Shutong, et al.
Publicado: (2018)

A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone
por: Resta, Lee P., et al.
Publicado: (2010)

Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids
por: Dinter, Jonas, et al.
Publicado: (2023)

A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer
por: Collins, R, et al.
Publicado: (2006)

Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells
por: Niemira, Magdalena, et al.
Publicado: (2020)

Mitoxantrone-Surfactant Interactions: A Physicochemical Overview
por: Enache, Mirela, et al.
Publicado: (2016)

Late Cardiotoxicity in MS Patients Treated with Mitoxantrone
por: Najafian, Jamshid, et al.
Publicado: (2019)

Sulfur inhibits the growth of androgen-independent prostate cancer in vivo
por: DUAN, FEI, et al.
Publicado: (2015)

Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia
por: Hata, Junya, et al.
Publicado: (2023)

Early Human Prostate Adenocarcinomas Harbor Androgen-Independent Cancer Cells
por: Fiñones, Rita R., et al.
Publicado: (2013)

Prostate-Specific Antigen Nadir and Time to Prostate-Specific Antigen Nadir Following Maximal Androgen Blockade Independently Predict Prognosis in Patients with Metastatic Prostate Cancer
por: Hong, Seok Young, et al.
Publicado: (2012)

Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion
por: Li, Yirong, et al.
Publicado: (2008)

The Effects of Matrine in Combination with Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer
por: Li, Qi, et al.
Publicado: (2019)

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens
por: Dart, D. A., et al.
Publicado: (2011)

Identification of androgen-regulated genes in human prostate
por: VAARALA, MARKKU H., et al.
Publicado: (2012)

Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells
por: Patrikidou, Anna, et al.
Publicado: (2011)

ONECUT2 as a key mediator of androgen receptor-independent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer
por: Choi, WonSeok William, et al.
Publicado: (2022)

S-Adenosylmethionine affects ERK1/2 and STAT3 pathway in androgen-independent prostate cancer cells
por: Schmidt, Thomas
Publicado: (2022)

Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells
por: Wang, Guohua, et al.
Publicado: (2008)

SHH-N non-canonically sustains androgen receptor activity in androgen-independent prostate cancer cells
por: Trnski, Diana, et al.
Publicado: (2021)

Toxicity Evaluation and Biomarker Selection with Validated Reference Gene in Embryonic Zebrafish Exposed to Mitoxantrone
por: Liu, Lili, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_84uo16v1lmmeo8cr68i63ead3o